^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CAR-20/19-T Cells

    i
    Other names: CAR-20/19-T Cells, CAR-20/19-T, Autologous T Cells Engineered to Contain an Anti CD19 and Anti CD20 scFv Coupled to CD3ζ and 4-1BB Signaling Domains, LV20.19 CAR T-cells
    Associations
    News
    Trials
    Company:
    Medical College of Wisconsin, Miltenyi Biotec
    Drug class:
    CD19-targeted CAR-T immunotherapy, CD20-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials